These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 18061284)

  • 21. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.
    Sonkusare S; Srinivasan K; Kaul C; Ramarao P
    Life Sci; 2005 May; 77(1):1-14. PubMed ID: 15848214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia.
    Sharma B; Singh N; Singh M; Jaggi AS
    Pharmacol Biochem Behav; 2008 Jun; 89(4):535-45. PubMed ID: 18343489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
    Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
    Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis.
    Kotani S; Yamauchi T; Teramoto T; Ogura H
    Chem Biol Interact; 2008 Sep; 175(1-3):227-30. PubMed ID: 18501884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KD-501, a standardized extract of Scrophularia buergeriana has both cognitive-enhancing and antioxidant activities in mice given scopolamine.
    Jeong EJ; Ma CJ; Lee KY; Kim SH; Sung SH; Kim YC
    J Ethnopharmacol; 2009 Jan; 121(1):98-105. PubMed ID: 18996178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
    Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
    Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
    Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
    Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
    Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
    Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
    Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nootropic, neuroprotective and neurotrophic effects of phloretin in scopolamine induced amnesia in mice.
    Ghumatkar PJ; Patil SP; Jain PD; Tambe RM; Sathaye S
    Pharmacol Biochem Behav; 2015 Aug; 135():182-91. PubMed ID: 26071678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing the number of 5-HT(1A)-receptors in cortex and hippocampus does not induce mnemonic deficits in mice.
    Bert B; Voigt JP; Kusserow H; Theuring F; Rex A; Fink H
    Pharmacol Biochem Behav; 2009 Mar; 92(1):76-81. PubMed ID: 19010345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG?
    Sambeth A; Riedel WJ; Smits LT; Blokland A
    Eur J Pharmacol; 2007 Oct; 572(2-3):151-9. PubMed ID: 17659275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus.
    Narimatsu N; Harada N; Kurihara H; Nakagata N; Sobue K; Okajima K
    J Pharmacol Exp Ther; 2009 Jul; 330(1):2-12. PubMed ID: 19318594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions.
    Zajaczkowski W; Danysz W
    Pharmacol Biochem Behav; 1997 Jan; 56(1):21-9. PubMed ID: 8981605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice.
    Kang SY; Lee KY; Koo KA; Yoon JS; Lim SW; Kim YC; Sung SH
    Life Sci; 2005 Feb; 76(15):1691-705. PubMed ID: 15698848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease.
    Spencer JP; Brown JT; Richardson JC; Medhurst AD; Sehmi SS; Calver AR; Randall AD
    Neuroscience; 2004; 129(1):49-54. PubMed ID: 15489027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.